soul trial oral semaglutide cardiovascular outcomes 2024 results mace SOUL: Bests Usual Care in High-Risk Type 2 Diabetes SOUL trial shows oral semaglutide

Always verify calculations match your specific research compound and protocols

We further confirm that the order of authors listed in the manuscript has been approved by all of us

Ideal Candidates You're likely a good candidate if you have BMI of 30+ (obesity) or 27+ with weight-related health conditions, have tried diet and exercise without sustained success, are ready to commit to healthier eating, want medically supervised, FDA-approved treatment, and can invest 6-12 months for optimal results

Stano, A., Nembrini, C., Swartz, M

Some protocols are daily, some weekly, some nightly, and some are used only as directed

Connecticut wants to roll back coverage, and Massachusetts MassHealth now limits weight-loss coverage to Zepbound with prior authorization